|1||NCT00255099||Completed||TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.||
||593||All||18 Years and older (Adult, Senior)||NCT00255099||CR006307
|December 2005||January 2007||July 2008||November 17, 2005||June 15, 2011|
|Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection||
||Other / Industry||
||80||All||18 Years and older (Adult, Senior)||NCT00959894||08-2070||September 2009||February 2014||May 2014||August 17, 2009||June 6, 2016||May 13, 2015||
† Study has passed its completion date and status has not been verified in more than two years.